Michel Languetin

Title: Michel Languetin: Innovator in Pharmaceutical Chemistry

Introduction

Michel Languetin is a notable inventor based in La Trinite, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of antihistamine compounds. His work has led to the creation of innovative solutions that address various health concerns.

Latest Patents

Languetin holds a patent for "Derivatives of terbutylphenyl-1-amino-4-hydroxybutane their preparation." This invention focuses on (4-substituted phenyl)4-oxy 1-aminobutane, represented by the general formula (I). The compounds involve a nitrogen atom or a specific carbon structure, with cyclic substituents that include xanthic and benzimidazolic groups. The patent also details processes for obtaining these compounds and their use in pharmaceutical compositions as antihistamine ingredients.

Career Highlights

Michel Languetin is associated with Laboratoire Theramex S.A., where he has contributed to various research initiatives. His expertise in pharmaceutical chemistry has been instrumental in advancing the company's product offerings. Languetin's innovative approach has positioned him as a key figure in the development of new therapeutic agents.

Collaborations

Throughout his career, Languetin has collaborated with esteemed colleagues, including Paule Bonnet and Remi Delansorne. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the research process.

Conclusion

Michel Languetin's contributions to pharmaceutical chemistry exemplify the impact of innovation in healthcare. His patent and collaborative efforts reflect a commitment to advancing medical science and improving patient outcomes.